USA AI in Drug Discovery Market

USA AI in Drug Discovery Market is expected to grow at a CAGR of 45.7%

According to latest research report published by MarketsandMarkets, the USA AI in Drug Discovery Market by Offering (Software, Service), Technology (Machine Learning, Deep Learning), Application (Cardiovascular, Metabolic, Neurodegenerative), End User (Pharma, Biotech,CROs) - Global Forecasts to 2027, is expected to grow at a CAGR of 45.7% from 2022 to 2027.

Here are some of the key trends that are expected to drive the growth of the AI in Drug Discovery Market in the USA:

  • Rising investments in healthcare: The USA is the world's largest healthcare spender, and the government and private organizations are investing heavily in the development of new drugs.
  • Rising prevalence of chronic diseases: Chronic diseases such as cancer, diabetes, and cardiovascular diseases are a major cause of death and disability in the USA. The rising prevalence of these diseases is driving the demand for new and innovative drugs.
  • Government support: The US Food and Drug Administration (FDA) has been supportive of the development of new technologies in the healthcare sector. The FDA has also been working with pharmaceutical companies to develop new regulations for AI-powered drug discovery.

Here are some statistics that support the forecast:

  • The USA is the world's largest healthcare spender, with $3.8 trillion spent on healthcare in 2020.
  • The prevalence of chronic diseases in the USA is high, with over 100 million people living with cancer, diabetes, and cardiovascular diseases.
  • The US Food and Drug Administration (FDA) has approved over 100 new drugs in the past five years.

The following are some of the key players in the AI in Drug Discovery Market in the USA:

  • Insilico Medicine: Insilico Medicine is a pharmaceutical company that uses AI to design new drugs. The company has a proprietary platform that can screen large datasets of molecules to identify potential drug candidates.
  • Exscientia: Exscientia is a pharmaceutical company that uses AI to design new drugs. The company has a proprietary platform that can predict the efficacy and toxicity of drugs.
  • Recursion Pharmaceuticals: Recursion Pharmaceuticals is a pharmaceutical company that uses AI to identify new drug targets. The company has a proprietary platform that can screen large datasets of genetic data to identify genes that are associated with diseases.

The AI in Drug Discovery Market in the USA is expected to continue to grow in the coming years. The growth of this market will be driven by the increasing demand for new and innovative drugs, the rising prevalence of chronic diseases, and government support for the development of new technologies.

Don’t miss out on business opportunities in Artificial Intelligence/AI in Drug Discovery Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Artificial Intelligence in Drug Discovery Market Size,  Share & Growth Report
Report Code
HIT 7445
PR Published ON
6/16/2023
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Artificial Intelligence in Drug Discovery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
...

Digital Virtual Assistant - MarketsandMarkets

Home